Peapack Gladstone Financial Corp Repligen Corp Transaction History
Peapack Gladstone Financial Corp
- $6.74 Billion
- Q1 2025
A detailed history of Peapack Gladstone Financial Corp transactions in Repligen Corp stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 2,091 shares of RGEN stock, worth $277,831. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,091
Previous 2,089
0.1%
Holding current value
$277,831
Previous $301,000
11.63%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RGEN
# of Institutions
495Shares Held
57.6MCall Options Held
75.6KPut Options Held
521K-
Black Rock Inc. New York, NY7.57MShares$1.01 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.57MShares$1.01 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$675 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$224 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.67MShares$222 Million0.04% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.37B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....